Clinical Trial Update: A Study of PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney Disease [Phase 1, Phase 2]

View source ↗

Summary

This document notes the completion of a Phase 1/2 clinical trial evaluating PRT-201 administered after arteriovenous graft creation in patients with chronic kid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• PRT-201

Snippet

Sponsor: Proteon Therapeutics | Conditions: Chronic Kidney Disease | Phase 1, Phase 2 | Status: COMPLETED